CIK 0001531177 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
Sight Sciences, Inc.
Sign in to watch- Ticker
- SGHT
- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 800625749
- Phone
- (415) 889-0550
- Business address
- 4040 CAMPBELL AVE,, SUITE 100, MENLO PARK, CA, 94025
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $652,777
- in 5 filings, $653K under 10b5-1 plans
Net −$652,777. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
- Badawi Paul −$268K President and CEO sold <1% of stake
- Bauerlein Alison −$224K Chief Operating Officer sold 4% of stake
- Badawi David −$71K Chief Technology Officer sold <1% of stake
- Rodberg James −$64K Chief Financial Officer sold 3% of stake
- Taylor Brenton −$26K EVP, Operations & R&D sold 1% of stake
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-10-01 | Badawi David Chief Technology Officer | Sale 10b5-1 | −7,797 | $9.05 | $71K | 1,975,075 |
| 2026-07-06 | Badawi David Chief Technology Officer | Sale 10b5-1 | −7,418 | $5.51 | $41K | 1,982,872 |
| 2026-04-02 | Badawi David Chief Technology Officer | Sale 10b5-1 | −8,168 | $3.48 | $28K | 1,990,290 |
| 2026-02-19 | Badawi David Chief Technology Officer | Option exercise | +21,270 | $0.23 | $5K | 1,998,458 |
| 2026-02-19 | Badawi David Chief Technology Officer | Option exercise · Stock Option (Right to Buy) | −21,270 | 0 | ||
| 2026-02-03 | Badawi David Chief Technology Officer | Grant or award | +64,915 | 1,977,188 | ||
| 2026-01-16 | Badawi David Chief Technology Officer | Sale 10b5-1 | −4,836 | $6.62 | $32K | 1,912,273 |
| 2026-01-06 | Badawi David Chief Technology Officer | Sale | −3,695 | $7.48 | $28K | 1,917,109 |
| 2026-01-05 | Badawi David Chief Technology Officer | Sale | −3,051 | $7.82 | $24K | 1,920,804 |
| 2026-01-02 | Badawi David Chief Technology Officer | Sale | −2,914 | $7.43 | $22K | 1,923,855 |
| 2025-12-26 | Badawi David Chief Technology Officer | Option exercise | +21,270 | $0.23 | $5K | 1,926,769 |
| 2025-12-26 | Badawi David Chief Technology Officer | Option exercise · Stock Option (Right to Buy) | −21,270 | 21,270 | ||
| 2025-10-03 | Badawi David Chief Technology Officer | Sale | −6,033 | $3.27 | $20K | 1,864,992 |
| 2025-07-17 | Badawi David Chief Technology Officer | Option exercise | +40,000 | $0.12 | $5K | 1,871,025 |
| 2025-07-17 | Badawi David Chief Technology Officer | Option exercise · Stock Option (Right to Buy) | −40,000 | 0 | ||
| 2025-07-03 | Badawi David Chief Technology Officer | Sale | −5,679 | $4.17 | $24K | 1,831,025 |
| 2025-04-01 | Badawi David Chief Technology Officer | Sale | −5,980 | $2.30 | $14K | 1,836,704 |
| 2025-03-11 | Badawi David Chief Technology Officer | Grant or award | +98,566 | 1,842,684 | ||
| 2025-01-17 | Badawi David Chief Technology Officer | Sale | −5,423 | $2.78 | $15K | 1,744,118 |
| 2025-01-08 | Badawi David Chief Technology Officer | Sale | −3,829 | $3.26 | $12K | 1,749,541 |
Page 1 of 2 · 22 trades